• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨苄西林的矛盾性抗菌效应:利用群体药代动力学模型评估菌血症婴儿中鹰效的临床相关因素

Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With Bacteremia.

机构信息

From the Department of Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania.

Department of Pediatrics, Duke University, Durham, North Carolina.

出版信息

Pediatr Infect Dis J. 2020 Aug;39(8):725-729. doi: 10.1097/INF.0000000000002663.

DOI:10.1097/INF.0000000000002663
PMID:32235247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8628496/
Abstract

BACKGROUND

High doses of ampicillin are often used to achieve therapeutic drug concentrations in infants. A paradoxical antibiotic effect, often called the Eagle effect, occurs when increasing concentrations of antibiotic above a threshold results in decreased efficacy. It is unknown if infants treated with ampicillin are at risk for this paradoxical effect.

METHODS

We identified infants <28 days of age with Escherichia coli, Enterococcus or Streptococcus agalactiae (group B streptococcus) bloodstream infections from 1997 to 2012 and previously included in an ampicillin pharmacokinetic (PK) modeling study. We compared the odds of death for ampicillin dose, estimated time above the minimum inhibitory concentration (T > MIC) and PK parameters using separate logistic regression models. Adjusted logistic regression and Poisson models were used to calculate the odds of prolonged bacteremia ≥3 days and the duration of bacteremia, respectively, for dose, T > MIC and multiple PK parameters.

RESULTS

Among 1272 infants meeting inclusion criteria, odds of death 7 or 30 days after the positive blood culture were not consistent with a paradoxical effect across any of the dosing regimens or PK parameters evaluated. The odds of prolonged bacteremia was lowest at the lowest dose category and the lowest daily dose category but not associated with the area-under-the-concentration time curve from 0 to 24 hours, or the maximum or minimum concentrations at steady state. T > MIC of ≥50% of the dosing interval was associated with decreased duration of bacteremia and odds of prolonged bacteremia.

CONCLUSIONS

It is unlikely that a paradoxical antibiotic effect will have a clinical correlate when ampicillin is used for neonatal bacteremia. A T > MIC ≥50% decreased both duration of bacteremia and odds of prolonged bacteremia.

摘要

背景

为了达到治疗药物浓度,婴儿常使用大剂量氨苄西林。当抗生素浓度超过阈值时,会出现一种反常的抗生素效应,通常称为“鹰效应”,从而导致疗效降低。目前尚不清楚接受氨苄西林治疗的婴儿是否存在这种反常效应的风险。

方法

我们从 1997 年至 2012 年期间,确定了 1272 例患有大肠埃希菌、肠球菌或无乳链球菌(B 组链球菌)血流感染且年龄<28 天的婴儿,并对其进行了氨苄西林药代动力学(PK)建模研究。我们分别使用逻辑回归模型比较了剂量、高于最低抑菌浓度(T > MIC)时间和 PK 参数的死亡几率。使用调整后的逻辑回归和泊松模型分别计算剂量、T > MIC 和多个 PK 参数与延长血培养阳性后 3 天以上的菌血症和菌血症持续时间的比值比。

结果

在符合纳入标准的 1272 例婴儿中,在任何给药方案或 PK 参数评估中,阳性血培养后 7 天或 30 天的死亡几率均不符合反常效应。在最低剂量组和最低日剂量组中,延长菌血症的几率最低,但与 0 至 24 小时的浓度时间曲线下面积或稳态时的最大或最小浓度无关。T > MIC 为给药间隔的 50%以上与减少菌血症持续时间和延长菌血症的几率相关。

结论

当氨苄西林用于新生儿菌血症时,不太可能出现反常抗生素效应的临床相关性。T > MIC≥50%可降低菌血症持续时间和延长菌血症的几率。

相似文献

1
Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With Bacteremia.氨苄西林的矛盾性抗菌效应:利用群体药代动力学模型评估菌血症婴儿中鹰效的临床相关因素
Pediatr Infect Dis J. 2020 Aug;39(8):725-729. doi: 10.1097/INF.0000000000002663.
2
Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.新生儿大肠杆菌血流感染:临床结局及初始抗生素治疗的影响
Pediatr Infect Dis J. 2015 Sep;34(9):933-6. doi: 10.1097/INF.0000000000000769.
3
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.低温治疗环境下低氧缺血性脑病新生儿氨苄西林的群体药代动力学和药效学靶点达标情况
Pharmacotherapy. 2017 Apr;37(4):456-463. doi: 10.1002/phar.1916. Epub 2017 Mar 30.
4
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.电子健康记录与药代动力学建模以评估新生儿氨苄西林暴露与癫痫发作风险之间的关系。
J Pediatr. 2016 Nov;178:125-129.e1. doi: 10.1016/j.jpeds.2016.07.011. Epub 2016 Aug 10.
5
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.利用机会性研究设计对新生儿氨苄西林群体药代动力学进行表征。
Antimicrob Agents Chemother. 2014 Jun;58(6):3013-20. doi: 10.1128/AAC.02374-13. Epub 2014 Mar 10.
6
Ampicillin Pharmacokinetics During First Week of Life in Preterm and Term Neonates.早产儿和足月新生儿生后第一周氨苄西林药代动力学。
Pediatr Infect Dis J. 2021 May 1;40(5):464-472. doi: 10.1097/INF.0000000000003061.
7
Prostatic Pharmacokinetic/Pharmacodynamic Evaluation of Ampicillin-Sulbactam for Bacterial Prostatitis and Preoperative Prophylaxis.氨苄西林-舒巴坦治疗细菌性前列腺炎和术前预防的前列腺药代动力学/药效学评价。
J Clin Pharmacol. 2021 Jun;61(6):820-831. doi: 10.1002/jcph.1800. Epub 2021 Jan 12.
8
Are postnatal ampicillin levels actually related to the duration of intrapartum antibiotic prophylaxis prior to delivery? A pharmacokinetic study in 120 neonates.产后氨苄西林水平是否真的与分娩前产时抗生素预防性应用的持续时间有关?一项针对120名新生儿的药代动力学研究。
Arch Dis Child Fetal Neonatal Ed. 2018 Mar;103(2):F152-F156. doi: 10.1136/archdischild-2016-312546. Epub 2017 Jun 29.
9
Prolonged Post-Discontinuation Antibiotic Exposure in Very Low Birth Weight Neonates at Risk for Early-Onset Sepsis.极低出生体重儿发生早发性败血症风险者,延长停药后抗生素暴露时间。
J Pediatric Infect Dis Soc. 2021 May 28;10(5):615-621. doi: 10.1093/jpids/piaa172.
10
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?首选用作严重感染治疗的β-内酰胺类抗生素的群体药代动力学模型:应在儿童中开哪种抗生素方案?
J Pharm Pharm Sci. 2020;23:470-485. doi: 10.18433/jpps30927.

引用本文的文献

1
Is It Possible to Optimize the Elaboration and Preservation of a Vancomycin Catheter Lock Solution?是否有可能优化万古霉素导管封管溶液的配制和保存?
Antibiotics (Basel). 2025 Jun 14;14(6):605. doi: 10.3390/antibiotics14060605.
2
Beta-Lactams Therapeutic Monitoring in Septic Children-What Target Are We Aiming for? A Scoping Review.脓毒症患儿的β-内酰胺类药物治疗监测——我们的目标是什么?一项范围综述。
Front Pediatr. 2022 Mar 10;10:777854. doi: 10.3389/fped.2022.777854. eCollection 2022.
3
Effect of Tranexamic Acid against Staphylococcus spp. and Cutibacterium acnes Associated with Peri-Implant Infection: Results from an Study.

本文引用的文献

1
Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.理解和应对 CLSI 折点修订:临床实验室的入门指南。
J Clin Microbiol. 2019 May 24;57(6). doi: 10.1128/JCM.00203-19. Print 2019 Jun.
2
Risk Factors for Complications in Children with Staphylococcus aureus Bacteremia.金黄色葡萄球菌菌血症患儿并发症的危险因素。
J Pediatr. 2019 May;208:214-220.e2. doi: 10.1016/j.jpeds.2018.12.002. Epub 2019 Mar 14.
3
Generating Robust and Informative Nonclinical and Bacterial Infection Model Efficacy Data To Support Translation to Humans.
氨甲环酸对与种植体周围感染相关的金黄色葡萄球菌和痤疮丙酸杆菌的影响:一项 研究的结果。
Microbiol Spectr. 2022 Feb 23;10(1):e0161221. doi: 10.1128/spectrum.01612-21. Epub 2022 Feb 16.
4
A Quantitative Survey of Bacterial Persistence in the Presence of Antibiotics: Towards Antipersister Antimicrobial Discovery.抗生素存在下细菌持续存在的定量研究:迈向抗持续菌抗菌药物的发现
Antibiotics (Basel). 2020 Aug 13;9(8):508. doi: 10.3390/antibiotics9080508.
生成稳健且信息丰富的非临床和细菌感染模型药效数据,以支持向人体的转化。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02307-18. Print 2019 May.
4
Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations.美罗培南高于最低抑菌浓度(MIC)的暴露时间可预测囊性纤维化患儿急性肺部加重期的治疗反应。
Diagn Microbiol Infect Dis. 2018 Jul;91(3):294-297. doi: 10.1016/j.diagmicrobio.2018.01.020. Epub 2018 Feb 24.
5
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.电子健康记录与药代动力学建模以评估新生儿氨苄西林暴露与癫痫发作风险之间的关系。
J Pediatr. 2016 Nov;178:125-129.e1. doi: 10.1016/j.jpeds.2016.07.011. Epub 2016 Aug 10.
6
Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.儿科肿瘤发热伴中性粒细胞减少症患者哌拉西林/他唑巴坦中哌拉西林成分的群体药代动力学。
Pediatr Blood Cancer. 2015 Mar;62(3):477-82. doi: 10.1002/pbc.25287. Epub 2014 Oct 18.
7
The Pediatrix BabySteps® Data Warehouse--a unique national resource for improving outcomes for neonates.Pediatrix BabySteps® 数据仓库——改善新生儿预后的独特国家资源。
Indian J Pediatr. 2015 Jan;82(1):71-9. doi: 10.1007/s12098-014-1585-2. Epub 2014 Oct 17.
8
Pharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients: a pilot study.重症患者中短时间输注与延长时间输注美罗培南给药的药代动力学:一项初步研究。
Crit Care Resusc. 2014 Sep;16(3):190-6.
9
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.利用机会性研究设计对新生儿氨苄西林群体药代动力学进行表征。
Antimicrob Agents Chemother. 2014 Jun;58(6):3013-20. doi: 10.1128/AAC.02374-13. Epub 2014 Mar 10.
10
Medication use in the neonatal intensive care unit.新生儿重症监护病房的药物使用情况。
Am J Perinatol. 2014 Oct;31(9):811-21. doi: 10.1055/s-0033-1361933. Epub 2013 Dec 17.